Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Cristian Pereda"'
Autor:
Andrés Tittarelli, Cristian Pereda, María A. Gleisner, Mercedes N. López, Iván Flores, Fabián Tempio, Alvaro Lladser, Adnane Achour, Fermín E. González, Claudia Durán-Aniotz, Juan P. Miranda, Milton Larrondo, Flavio Salazar-Onfray
Publikováno v:
Vaccines, Vol 12, Iss 4, p 357 (2024)
Cancer vaccines present a promising avenue for treating immune checkpoint blockers (ICBs)-refractory patients, fostering immune responses to modulate the tumor microenvironment. We revisit a phase I/II trial using Tumor Antigen-Presenting Cells (TAPC
Externí odkaz:
https://doaj.org/article/de619fa28af44adebdfdd1e2b4a8fc4d
Autor:
Bernardita Medel, Cristobal Costoya, Dominique Fernandez, Cristian Pereda, Alvaro Lladser, Daniela Sauma, Rodrigo Pacheco, Takao Iwawaki, Flavio Salazar-Onfray, Fabiola Osorio
Publikováno v:
Frontiers in Immunology, Vol 9 (2019)
The IRE1α/XBP1s signaling pathway is an arm of the unfolded protein response (UPR) that safeguards the fidelity of the cellular proteome during endoplasmic reticulum (ER) stress, and that has also emerged as a key regulator of dendritic cell (DC) ho
Externí odkaz:
https://doaj.org/article/f5d302f4c97d41bba6f8f35f97a26b09
Autor:
Daniel Alberto Rojas-Sepúlveda, Mª Alejandra Gleisner, Cristian Pereda, Mercedes López, Flavio Salazar-Onfray
Publikováno v:
The Journal of Immunology. 198:79.18-79.18
Introduction Although infrequent, Gallbladder cancer (GBC) has high incidence rates in South America. In fact, Chile has the highest GBC incidence and mortality worldwide. Currently, surgery is the only effective treatment, and the five-year survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1913e369cd805d8c5bf3dd860ff7fc39
https://doi.org/10.4049/jimmunol.198.supp.79.18
https://doi.org/10.4049/jimmunol.198.supp.79.18
Publikováno v:
Revista Chilena de Salud Pública. 10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b237fb4a452fda69a7d029775c1ab1a
https://doi.org/10.5354/0717-3652.2006.2719
https://doi.org/10.5354/0717-3652.2006.2719
Autor:
María Alejandra Gleisner, Cristián Pereda, Andrés Tittarelli, Mariela Navarrete, Camila Fuentes, Ignacio Ávalos, Fabian Tempio, Juan Pablo Araya, María Inés Becker, Fermín Eduardo González, Mercedes Natalia López, Flavio Salazar-Onfray
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Immune checkpoint blocker (ICB) therapy has shown survival benefits for some patients with cancer. Nevertheless, many individuals remain refractory or acquire resistance to treatment, motivating the exploration of complementary immunothera
Externí odkaz:
https://doaj.org/article/28c908f8ce38455c8c9cfa54e97678c0
Autor:
Iván Flores, Daniel Hevia, Andrés Tittarelli, Dafne Soto, Daniel Rojas-Sepúlveda, Cristián Pereda, Fabián Tempio, Camila Fuentes, Cristian Falcón-Beas, Jimena Gatica, Felipe Falcón-Beas, Mario Galindo, Flavio Salazar-Onfray, Fermín E. González, Mercedes N. López
Publikováno v:
Journal of Immunology Research, Vol 2019 (2019)
Ovarian epithelial carcinoma (OEC) is the most frequent ovarian tumor, characterized by a high mortality in advanced stages where conventional therapies are not effective. Based on the role of the immune system in the progression of this disease, imm
Externí odkaz:
https://doaj.org/article/27606a5c810546ba836ac9c1fa8ce926
Autor:
Fermín E. González, Alexey Chernobrovkin, Cristián Pereda, Tamara García-Salum, Andrés Tittarelli, Mercedes N. López, Flavio Salazar-Onfray, Roman A. Zubarev
Publikováno v:
Journal of Immunology Research, Vol 2018 (2018)
Autologous dendritic cells (DCs) loaded with cancer cell-derived lysates have become a promising tool in cancer immunotherapy. During the last decade, we demonstrated that vaccination of advanced melanoma patients with autologous tumor antigen presen
Externí odkaz:
https://doaj.org/article/ef1825395fd746dcb5cfe14ad9714aa3
Publikováno v:
Biological Research, Vol 46, Iss 4, Pp 431-440 (2013)
Here we summarize 10 years of effort in the development of a biomedical innovation with global projections. This innovation consists of a novel method for the production of therapeutic dendritic-like cells called Tumor Antigen Presenting Cells (TAPCe
Externí odkaz:
https://doaj.org/article/f142821d88cd4d78bbb1aa6ad7bc665d